Author: admin

  • Illegal Drugs Get Cheaper, More Potent

    Illegal Drugs Get Cheaper, More Potent

    Sometimes my work as a drug policy analyst is really hard to explain to my non-drug policy friends. Most of the research findings about drug policy that I deal with on a daily basis fly in the face of conventional wisdom about drugs, drug users and drug laws. One of these pieces of conventional wisdom taught routinely to Canadian high school students is that drug law enforcement is necessary to keep the supply of illegal drug under control, and to discourage young people especially, from using these drugs.

    Change in estimated heroin price and purity in the context of the annual drug control budget in the United States. Source: Global Commission on Drug Policy
    Change in estimated heroin price and purity in the context of the annual drug control budget in the United States. Source: Global Commission on Drug Policy

    As any of you in the field of drug policy reform know, despite the claims by police, drugs are now more available, higher purity and more potent than they were 20 years ago. So says a recent publication in the British Journal of Medicine Open, entitled, “The temporal relationship between drug supply indicators: An audit of international government surveillance systems.” Whew that’s mouthful. Authors of this study at the BC based International Centre for Science in Drug Policy culled from two decades (1990 to 2010) of government databases on illegal drug supply, and found the supply of major illegal drugs has (with a few exceptions) increased. With the exception of powder cocaine, the purity and/or potency of illegal drugs in the U.S. generally increased. Their findings also confirm that the price of illegal drugs generally decreased.

    These findings once again throw into question the effectiveness of current government drug policies that emphasize supply reduction at the expense of other goals. These deficiencies are aptly illustrated by the World Drug Report, an annual publication of the United Nations Office on drugs and Crime that relies on reports of police drug seizures (i.e. size and estimates of drugs found in raids) along with police-based estimates of crop size (i.e. for cannabis and coca) to evaluate the effectiveness of drug policies. The larger the seizure, the more enforcement officials assert the effectiveness of their approaches.  But the findings described above suggest that no matter how hard we try to apply supply-side drug enforcement, drugs are still widely available, cheap and increasingly potent.

    As the authors of this study suggest, new measures of the success of drug policies are urgently needed. Rather than using measures of drug supply, its time for governments to assess the effectiveness of their drug policies by using indicators of drug-related harm like overdoses, rates of blood-borne disease transmission (i.e. HIV or Hep C) and emergency room visits…you get the picture. And as the Global Commission on Drug Policy reports, supply-side drug enforcement actually exacerbates the problem of drugs by driving people away from supports and services, at the same time as it creates a growing underground market in drugs.

    Sounds sensible, but Canada has poor quality data for measuring the health of people who use drugs. The Canadian Alcohol and Drug Use Monitoring Survey is small and relies on the use of land-lines. There’s no national level data on drug overdoses like there is in the U.S. This lack of data seemingly reinforces the proposition that if you can’t count it, it’s not a problem.

    We do know how many people are arrested for drug crimes (57,000 plus for cannabis possession in 2012). But these measures only tell us about police priorities, though they do suggest that the criminalization of people who use drugs is a major way Canada attempts to limit drug use – an approach shown to be less than effective at stopping drug use and a key driver of stigma and discrimination.

    So it’s time for all of us to sit down with our friends and family and explain that the conventional maxims of drug policy fail to keep us safe, do not limit the supply of drugs and overlook the health and other needs of people who use drugs.  Clearly it’s time for a new approach.

  • 9/30

    9/30

    930-Campaign-2013_Banner_FINAL

    It’s 9/30 and way past time for the federal government to get moving on safer consumption services.

    September 30, 2013 (9/30) marks the two-year anniversary of Canada’s Supreme Court decision that unanimously granted constitutional protection to Vancouver’s supervised injection site, Insite. To mark this important anniversary, the Canadian Drug Policy Coalition is spearheading a campaign to let our federal government know that there is widespread support for safer consumption services. In conjunction with the Canadian HIV/AIDS Legal Network and PIVOT Legal Society, we’ve created a sign-on letter to federal Minister of Health Rona Ambrose. Our letter demands that the federal government get going in the right direction to support the scale up of these important and life-saving services.

    That decision recognized the improved public health and public order that stems from the implementation of this service. The Court also recognized that, under the Canadian Charter of Rights and Freedoms, people who need such life-saving health services should not face possible criminal prosecution and imprisonment for attempting to use them. The decision created an important precedent supportive of expanding similar services in other communities.

    An overwhelming amount of research evidence on supervised injection sites (SIS) has been published in a wide range of scientific and medical journals since Insite first opened its doors in 2003. The evidence of Insite’s positive benefits is conclusive and these services should be scaled up where needed across Canada. Indeed numerous localities are working towards this.

    Supervised consumption services (SCS) have been proven to:

    • decrease overdose death and injury;
    • decrease risk behaviours associated with HIV and hepatitis C infection;
    • increase access to health services for people who are most marginalized;
    • save health care costs; and
    • decrease open drug use and publicly discarded drug use equipment.

    Furthermore, the evidence shows that such services do not increase crime, nor do they increase drug use.

    There are over 90 SCSs operating around the world today, and considerable research about the positive public health and safety outcomes of SISs. There is also broad agreement among health professionals that SCSs should be part of a comprehensive continuum of health services for people who use drugs.

    INSITE, Vancouver BC
    INSITE, Vancouver BC

    On September 30, 2011, the Supreme Court of Canada (SCC) ruled that it would infringe constitutional rights to security of the person to deny an exemption from the provisions of the Controlled Drugs and Substances Act so that Insite could operate without staff or users fearing criminal prosecution when using this health service. The Court declared unequivocally: “Insite saves lives. Its benefits have been proven.” The Court also stated: “Where, as here, a supervised injection site will decrease the risk of death and disease, and there is little or no evidence that it will have a negative impact on public safety, the Minister should generally grant an exemption.”

    All across Canada organizations of people who use drugs, front-line organizations, researchers, professionals, and community members who work with people who use drugs, are demanding increased access to supervised consumption services. It is unacceptable that a decade after Insite first opened, Vancouver remains the only city in Canada with a sanctioned supervised consumption service – and only one such service of this sort, which numerous studies have demonstrated is simply inadequate to meet local needs.

    It is unethical, unconstitutional and damaging to both public health and the public purse to block access to supervised consumption services which save lives and prevent the spread of infection.

    It’s time to stand up for people’s lives and take the leadership to ensure that supervised consumption services become a part of the continuum of care for people who use drugs in Canada.

  • Overdose Awareness Requires Federal Attention

    Overdose Awareness Requires Federal Attention

    Overdose-Awareness-Day-2013_Facebook-share-Image_CDPC1Today the White House based Office of National Drug Control (ONCDP) released a letter in honour of International Overdose Awareness Day (August 31st). The take home message of the letter emphasizes Obama’s support for overdose initiatives and announces the release of the new toolkit on opioid overdose. As the letter states:

    “This toolkit builds upon our efforts to expand prevention and treatment.  It also promotes the use of naloxone, a life-saving overdose reversal drug which we believe should be in the patrol cars of every law enforcement professional across the nation. Please join us in spreading the word about overdose prevention by sharing a link to this toolkit on your social media platforms.”

    Let’s be clear about one thing: in the slow-moving world of drug policy reform, this is a major step forward. Prior U.S. administrations condemned the use of naloxone to treat opioid overdoses and this one supports it use. In fact, check out the outgoing head of the ONDCP Gil Kerlikowske’s interview with the Washington Post. Kerlikowske mentions the importance of naloxone in this interview and talks about the necessity of evidence-based drug policy reform. This interview comes on the heel’s of yesterday’s announcement that the U.S. Federal government will allow marijuana legalization laws to proceed in Colorado and Washington.

    I don’t want to romanticize the US approach. That government still supports Plan Colombia, an expensive and wasted effort to eradicate coca growing. But change is definitely in the air.

    Unfortunately, the Canadian federal government is nowhere near making similar pronouncements or providing any sort of open support for overdose prevention and treatment initiatives. The CDPC has written to Health Minister Rona Ambrose to emphasize the need for a national overdose strategy that includes harm reduction approaches like take-away naloxone programs. These programs train overdose witnesses to respond effectively to overdose and to prevent them from occurring in the future.

    The math is simple on this one – these programs save lives, so why I ask is Canada now falling behind the US on these initiatives? International Overdose Awareness Day is an opportunity to honour those we’ve lost to overdose but it’s also a time to reflect on how we can do better in Canada.

  • How a Prorogued Parliament Could Help Harm Reduction

    How a Prorogued Parliament Could Help Harm Reduction

    Today the Conservative government prorogued the Canadian parliament. What this means is that the current legislative agenda, on hold when parliament recessed for the summer, is now dead. This move does not come as much of a surprise given the recent cabinet shuffle that signaled some shifts in direction for the current government, and prorogation will give them a chance to reboot its legislative and parliamentary agenda.

    This is potentially good news for those of us who have been watching the progression of Bill C-65 (Respect for Communities act). The extensive provisions of Bill C-65 promised to make it more difficult to implement new supervised injection services in Canada because of the myriad levels of approval that service providers would need to demonstrate in their applications (potential service providers must make an application to the federal Minister of Health for an exemption to the Controlled Drugs and Substances Act if they wish to shield clients and staff from potential drug charges). Now that Bill C-65 is dead it gives us some breathing room to continue to work on getting more supervised injection services in Canada.

    But dead does not necessarily mean buried. The CDPC will be watching closely when the Harper government announces its new legislative agenda in the fall. There’s always the chance the Harper government could reintroduce the bill in either its current form or as a revised attempt to muzzle harm reduction in Canada. Stay tuned. You know we will be.

    In the meantime, September 30, 2013 (9/30) is the second anniversary of the Supreme Court of Canada’s decision that allowed Insite (Vancouver’s supervised injection site) to stay open. The CDPC is working with our partners across the country to encourage local groups to host events and activities that mark this important occasion and raise the profile of safer consumption services in Canada. We hope you will join or help organize one of these events in your community.

    For organizations: Consider creating a mock injection site open to the public and the media and ask local supportive nurses to be on hand to answer questions. You might also want to do something simple like creating a media release making the case for these services in your city.

    For individuals: Send a letter to the local paper expressing your dismay at the lack of support for safer consumption services in your region or write an editorial for you local paper and along the lines of the letter suggested above. Visit your local MP, mayor, or other politicians and make the case for these services in your community. Let them know that the safety and health of every member of your community is important and that’s why you support these services. And don’t forget to the write letters to the Prime Minister’s Office expressing your concerns about the lack of federal support for harm reduction services.

    We are creating a tool kit of ideas for this day so contact Connie Carter if you would like more information.

  • The Harm Reduction debate: Political Expedience vs Progress

    The Harm Reduction debate: Political Expedience vs Progress

    On June 24th, the Urban Health Research Institute released a report on 15 years of data on drug use in the city of Vancouver. The results of their analysis are significant, but predictable to those who work in the field – harm reduction has saved lives and led to a decrease in drug use, while the war on drugs had failed to do either.

    Since the mid 1990’s, the number of people sharing needles has fallen dramatically while usage of needle exchange services and methadone treatment programs has increased. This means that far fewer people are getting HIV and Hep C from drug use and fewer are dying of overdoses because of services like Insite. Such would not have been possible without key champions and advocates from across the spectrum including health, municipal, and police officials, and of course organizations of people who use drugs including VANDU.

    An equally apparent takeaway from this report is that the “war on drugs” in Vancouver has completely failed to meet any of its objectives. Data from the same 15 years shows that despite the millions spent on drug enforcement and interdiction, drug availability and pricing has remained unaffected and stable.

    The findings in this report also illuminate the many misperceptions about harm reduction services that we often see in the media. One such misperception is that harm reduction services are somehow the opposite of abstinence-based drug treatment. In fact, when people access harm reduction services, including unused drug use supply distribution and methadone, they are often taking the first step towards abstinence and recovery.

    The Conservative Party of Canada is capitalizing on these misperceptions to support and promote the introduction of Bill C-65, the Respect for Communities Act. This legislation, if passed, will make it more difficult to set up life-saving supervised injection services in other parts of the country and is part of a sustained attack on harm reduction programs by the government’s National Anti-Drug Strategy.

    We know from talking with people from across the country, that many Canadians are concerned about this hostility to well-established harm reduction services, which are supported by organizations such as the United Nations Office on Drugs and Crime, UNAIDS, and the World Health Organization.

    It’s time to take a deeper look at the myths about harm reduction and expose them for what they are – politically expedient and uninformed dismissals of well-researched and successful health care services. It comes down to a rather obvious choice: Do we want people to use drugs openly in our streets or in other unsafe and unhygienic conditions, or do want to provide services that have shown to engage people in life-saving health care and drug treatment? It’s as simple as that and the Urban Health Research Institute’s report underscores this point with a wealth of data.

    Harm reduction services are based on a pragmatic, non-judgmental approach to the provision of health services that respects the dignity of people who use drugs and values their human rights. Because these services have minimal requirements for involvement, they are often the first points of entry to other health and social services.

    Harm reduction is not the only approach to problematic substance use but it is a major means of preventing the transmission of disease, overdose and death, connecting people to services and opening a pathway to change. These services have key secondary benefits such as increased access to health services, housing referrals, referrals to drug treatment, counseling, education, and testing for HIV and HCV.

    So next time you hear politicians saying they favour drug treatment over harm reduction consider the possibility that these services are part of the same continuum and ask them why they keep repeating these myths despite the existence of so much evidence to the contrary.

  • Why Decriminalize Drugs?

    Why Decriminalize Drugs?

    On Thursday, May 24th the Canadian Drug Policy Coalition released a report on Canadian drug policy. The report calls for the replacement of Canada’s National Anti-Drug Strategy with one focused on health and human rights, the scale-up of comprehensive health and social services, including housing and treatment services that engage people with drug problems; more robust educational programs about safer drug use, the decriminalization of all drugs for personal use and the creation of a regulatory system for adult cannabis use.

    The Canadian media responded quickly to our recommendation to decriminalize personal possession of drugs with questions about how this approach would work, especially when it comes to drugs like heroin and cocaine. Canada’s Conservative government also reacted swiftly to media coverage of our report and publicly dismissed our proposal to decriminalize the personal use of all other drugs.

    Let’s be very clear about what the Canadian Drug Policy Coalition is recommending: the full legal regulation of cannabis for adult use and the decriminalization of possession of small quantities of all other drugs for personal use. We do not at this time recommend full legal regulation of drugs other than cannabis; nor do we suggest that all currently illegal drugs should become widely available. Decriminalization of possession of these drugs will not address the harms associated with an underground market. But it is a first step towards a more effective policy. Decriminalization, a strategy currently in use by up to 30 countries world-wide, has been quietly adopted in the wake of the escalating costs of prohibition and its failure to stem the tide of drug use and eliminate drug markets.

    Politicians still insist that decriminalizing drug use would send the “wrong message”. This idea is grounded in the false belief that criminalizing drugs keeps people from using them and lessening penalties for drug use will in fact result in higher rates of drug use.  But in countries and regions where decriminalization has been implemented, this has just not been the case. As the Global Commission on Drug Policy suggested in 2011,

    “A key idea behind the ‘war on drugs’ approach was that the threat of arrest and harsh punishment would deter people from using drugs. In practice, this hypothesis has been disproved – many countries that have enacted harsh laws and implemented widespread arrest and imprisonment of drug users and low-level dealers have higher levels of drug use and related problems than countries with more tolerant approaches. Similarly, countries that have introduced decriminalization, or other forms of reduction in arrest or punishment, have not seen the rises in drug use or dependence rates that had been feared.”

    International comparisons also show us that there is no correlation between the harshness of enforcement and the prevalence of drug use. Even in states that have decriminalized all drugs, the sky has not fallen. In 2000, Portugal moved to decriminalize all drugs, including cocaine and heroin, at the same time as it scaled up the availability of services to address drug use problems. By moving personal possession away from law enforcement, drug use did not rise significantly, especially when compared with neighbouring countries. Portugal has also seen a reduction in illegal drug use among problematic drug users and teens, a reduced burden on the criminal justice system, and a significant drop in HIV infections and drug-related deaths.

    Prohibition has failed. Drug use is still high, incarceration for drug offenses is increasing and despite billions of dollars spent over the years, law enforcement has failed to meet its objectives of protecting public health and public safety.

    One of the drugs that causes the most health and public safety harms – alcohol — is completely legal and widely available yet other drugs with a relatively small public health footprint remain completely illegal. Using the criminal law to discourage a behaviour like drug use only throws the law into disrepute because a complex phenomena like harmful drug use is the result of many factors, none of which the law, police, courts or prisons are prepared to address.

    In preparing our report, we talked to people across the country – service providers, family members, people who use drugs — and they told us again and again that Canada’s outdated approach to drug policy is hurting our citizens. In fact, using law enforcement to curb drug use increases its harms by driving it into the shadows. The criminalization of drug use also makes it more difficult to engage people in vital and life-saving health care services.

    We need to overhaul our approach to drugs. Globally, the current system of drug control is under considerable pressure to change. Some national governments have begun to chart their own paths when it comes to drug control, including experimenting with decriminalization. It’s time to follow suit, and modernise Canada’s legislative, policy and regulatory frameworks that address drugs.

  • CDPC Report on Drug Policy Highlights the Failures of Criminalization

    CDPC Report on Drug Policy Highlights the Failures of Criminalization

    On Thursday, May 23, CDPC released the first- ever comprehensive report by a civil society organization on the failures of Canada’s approach to drug policy. The report calls for the replacement of the current national anti-drug strategy with one focused on health and human rights; the decriminalization of all drugs for personal use; the creation of a regulatory system for adult cannabis use, increased efforts to eliminate stigma and discrimination against people who use drugs, the scale up of comprehensive health and social services, including housing and treatment services that engage people with drug problems; more robust educational programs about safer drug use, programs for distributing new supplies for injection and crack cocaine use, safer consumption services, opioid substitution therapies and heroin-assisted treatment and the collection and monitoring of data on drug use and its effects in Canada.

    All of these measures are designed to reduce harm from substance use in Canada and assist people who develop problems with drugs to get the help they need.

    Canadian media responded quickly to our recommendation to decriminalize personal possession of drugs with questions about how this approach would increase the safety and health of Canadians, especially when it comes to so-called “hard” drugs like heroin and cocaine. Canada’s Conservative government also reacted swiftly to media coverage of our report and publicly dismissed our proposal to decriminalize the personal use of all other drugs, while failing to adequately justify their current approach, which has shifted focus from a public health approach to drugs back to one that relies heavily on the criminal justice system.

    Our recommendations were shaped by the stories Canadians told us as we prepared this report. The CDPC talked to people across the country – service providers, family members, and people who use drugs. Story after story, along with research evidence, confirmed that the harms of drug use are exacerbated by Canada’s current drug policies. Canada still puts the majority of its resources behind conventional approaches to drug control like policing, courts, and prisons – approaches that have failed to meet their objectives – public health and public safety. In fact, Canada’s national drug policy increases the harms of substance use by driving it into the shadows and away from life-saving services. And like the United States, Canada’s drug laws disproportionally target already marginalized groups.

    Our report rues that fact that Canada used to be a leader when it came to progressive drug policy. Before the current federal government took power, harm reduction was a key pillar of the federal drug strategy, and the federal government supported innovative approaches like supervised injection sites, heroin assisted treatment and the expansion of needle exchange programs as well as focusing on prevention through social development rather than “Just Say No to Drugs” style of programs that have been shown not to work. Since 2007, Prime Minister Stephen Harper’s approach is best represented by the National Anti-Drug Strategy; a yet to be proven effort that reasserts the use of criminal law to suppress the trade and use of illegal substances.

    Our report documents how this approach, encapsulated by last year’s enactment of minimum sentencing provisions for some drug crimes, neither supports health or public safety but will lead to increasingly overcrowded and costly prisons. But the most stunning display of unimaginative thinking when it comes to solving current drug problems is the refusal by our government to even talk about the failures of the overarching policy framework and the criminalization of drugs and prohibition – policies that not only create much of the drug crime in Canada, but also constrain our ability to address many drug-related health harms. In fact, the Canadian government was one of the few that voted against the 2012 motion at the UN put forward by the President of Mexico to have a United Nations General Assembly Special Sesssion on global drug policy in 2016.

    Even where provincial level policies attempt to make “every door the right door” people still fall between the cracks, or wait intolerably long for drug treatment services because private treatment is prohibitively expensive and the publicly funded workforce whose role it is to provide these services is small.

    In many places in Canada, the harms associated with drug use continue unabated because we can’t commit fully to services like needle exchanges and supervised injection sites that help reduce these harms. The federal government remains openly hostile to evidence-based measures like key harm reduction services. As a result, rates of HIV and HCV associated with drug use remain unacceptably high, particularly among some groups of Canadians. In 2010, 30.4% of new infections in women versus 13.5 % of new cases in men were attributed to injection drug use. Cases of HIV attributed to injecting drug use among First Nations, Métis and Inuit persons have gone up to more than 50% in the period spanning 2001 to 2008. This is a tragedy and a national disgrace that can be prevented.

    Canada must modernize its approach to drugs. Globally, the current system of drug control is under considerable pressure to change and some jurisdictions have begun to chart their own paths when it comes to drug control, including experimenting with decriminalization and legal regulation of cannabis while over 70 countries embrace harm reduction in their drug strategy policy frameworks. The CDPC’s report recommends that it’s time to follow suit and modernise Canada’s legislative, policy and regulatory frameworks that address psychoactive substances.

  • New Supervised Injection Rules: Does the Government Really Care about Communities?

    New Supervised Injection Rules: Does the Government Really Care about Communities?

    On June 6, 2013, the Conservative government tabled amendments to the Controlled Drugs and Substances Act that creates 20 additional conditions required for applications for supervised consumption services. Entitled the “Respect for Communities Act”, these amendments essentially give police, public safety officials, and municipalities a veto over health services. The tabling of these amendments is clearly an attempt to head off applications expected within the year from a number of Canadian cities. Media coverage was swift and mixed. But the both the Canadian Medical Association and the Canadian Nurses Association quickly condemned the legislation and chastised the government for letting fear trump sound scientific evidence. Immediately following the release the Canadian HIV/AIDS Legal Network, the Canadian Drug Policy Coalition and PIVOT Legal Society issued a media release challenging these amendments.

    The new requirements will not only be costly and time consuming but they will likely prevent the expansion of these much-needed services. The intention of the legislation seems to be to give a broad range of community members an opportunity to comment on any proposal to create a service. There’s a sense of grievance in the government’s press releases that somehow communities have been excluded from playing a role in deciding the fate of these services. It seems ironic given the heavy-handed approach used by the Harper government, that suddenly they care about what communities think. What’s more likely is that they care about what the opponents of these services think. Of course communities should play a part in these discussions. But we can’t let one group of people, guided by fear and ignorance, prevent the implementation of life-saving and cost-effective services.

    No sooner had the legislation been tabled than an email blast from the Conservative Party to its members whipped up fears about supervised consumption services. Entitled “Keep heroin out of our backyards”, the CP missive uses language like “do you want a supervised drug consumption site in your community”. Clearly this is an attempt to stir up opposition to these life-saving services and to the people who use these services. Do they not realize that the “addicts” they fear so much are potentially their family and friends? We need to stop treating substance use as an “us” and “them” issue. At some point in our lives, many of us have been, or will be, touched by drugs and alcohol.

    In the last 20 years, supervised injection services (SIS) have been integrated into drug treatment and harm reduction programs in Western Europe, Australia and Canada. These services grew out of the recognition that low-threshold, easily accessible programs to reduce the incidence of blood-borne pathogens were effective and cost efficient. Since 2003, the city of Vancouver has been the location of a rigorously evaluated and highly successful stand-alone supervised injection site (SIS). More than 30 peer-reviewed studies describing the impacts of Insite indicate that it has several beneficial outcomes. The service is used by the people it was intended to serve, which includes over 10,000 clients. It is being used by people who would otherwise inject drugs in public spaces. Insite has reduced the sharing of needles and provided education on safer injecting practices. Insite has promoted entry into treatment for drug dependence and has improved public order. It has also been found to reduce overdose deaths and provide safety for women who inject drugs.

  • Safer Consumption Services – Plans are Underway for More Than Two

    Safer Consumption Services – Plans are Underway for More Than Two

    Several cities in Canada are planning for the implementation of safer consumption services in their communities.

    That was the conclusion of the speakers at a lively event on the feasibility of scaling up supervised consumption services in Canada held at the recent Canadian Association of HIV Care (CAHR) conference in Vancouver. Sponsored by the Dr. Peter Centre, the Canadian HIV/AIDS Legal Network and the Canadian Drug Policy Coalition, this half-day workshop brought together speakers from Ottawa, Montreal, Toronto and Vancouver to discuss their plans for the scale-up of these services across the country.

    The most famous of these services is Insite, located in Vancouver, BC. The vast amount of evidence from the reviews conducted on Insite suggest that this unique service has several beneficial outcomes: it is used by the people it was intended to serve, which includes over 10,000 clients. And it’s being used by people who might ordinary inject drugs in public. This service has also reduced risk behaviours by reducing the sharing of needles and providing education on safer injecting practices. Insite has promoted entry into treatment for drug dependency and has improved public order. It has also been found to reduce overdose deaths, provide safety for women who inject drugs, and does not lead to increased drug use or increased crime.[i]

    But public opposition and political fears still plague the scale up of these services. Despite well-documented benefits, opponents still claim that these services “promote” illegal drug use. These claims are based on the false assumption that failing to provide health care services to people who use drugs will dissuade drug use itself. All this does is drive people away from health care and into less safe injecting practices that can result in injury, infection and death. These opponents fail to appreciate that these services promote engagement in health care for hard-to-reach populations, and protect the dignity of people who use drugs by prioritizing their health care concerns.

    Formal opposition coming from the federal government has stalled the implementation of these beneficial services even in BC. In 2007, the federal government refused to grant a continuation of the legal exemption to Insite (Section 56 of the Controlled Drugs and Substances Act (CDSA)). Proponents of the site, including the PHS Community Services Society, VANDU, and Vancouver Coastal Health, challenged this refusal all the way to Canada’s Supreme Court. In 2011, that Court ruled in favour of the exemption noting the rights of people to access this health service, and ordered the federal Minister of Health to grant a continuation of the exemption. Future sites will be required to make an application for a section 56 exemption to avoid criminal charge for violations of the CDSA.

    It looks like the process of making an application for a Section 56 exemption will be onerous. Because of these challenges, some speakers at the CAHR conference urged the audience to consider other options like less expensive unsanctioned sites that use peer-run models of care.

    The need is clear – the will is there – the results are in.  Let’s urge the federal government to make access to these services as easy as possible so we can save lives, prevent illness and protect the dignity of people who use drugs.

    If you would like to help us advance the implementation of safer consumption services in Canada, please consider making a donation to the CDPC. And if you would like to keep up to date with our campaigns, sign up to our mailing list.